Table 1.
The clinical characteristics of patients without and with diabetes.
| Group of patients without diabetes | Group of patients with diabetes | p value | ||||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||
| miR-31-5p/100 μl of serum | 1366.33 | 2054.54 | 1146.97 | 1953.03 | 0.332 | |
| Duration of the CIDP (years) | 5.35 | 3.07 | 5.24 | 3.42 | 0.688 | |
| Duration of IgIV treatment (months) | 17.16 | 13.01 | 12.00 | 14.90 | 0.076 | |
| Body weight (kg) | 87.32 | 20.27 | 90.24 | 20.12 | 0.726 | |
| INCAT upper limbs | 1.94 | 1.00 | 1.12 | 0.70 | 0.005 | |
| INCAT lower limbs | 1.97 | 1.17 | 1.41 | 0.80 | 0.086 | |
| Serum | CK (IU/l) | 279.13 | 197.57 | 250.59 | 194.48 | 0.698 |
| Cerebrospinal fluid | IgG (g/l) | 10.95 | 2.87 | 10.55 | 1.86 | 0846 |
| IgA (g/l) | 2.29 | 0.86 | 2.65 | 1.28 | 0.532 | |
| IgM (g/l) |
1.18 | 0.83 | 0.87 | 0.63 | 0.200 | |
| Pleocytosis (cells/μl) | 3.43 | 2.49 | 4.18 | 3.70 | 0.796 | |
| Protein (mg/dl) | 72.39 | 37.20 | 7741 | 30.66 | 0.499 | |
| Age (years) | 59.23 | 11.93 | 65.94 | 10.40 | 0.070 | |
| ni | 31 | 17 | ||||
| Gender | F = 8 | M = 23 | F = 0 | M = 17 | ||
Abbreviation: ni: number of patients in the group.